News | Proton Therapy | July 29, 2015

Willis-Knighton Cancer Center Approaches First Anniversary With IBA’s Proteus One System

Cancer teams able to treat up to 20 patients per day with compact intensity modulated proton therapy system

IBA, Proteus One, compact proton therapy system, Willis-Knighton Cancer Center

July 29, 2015 — Teams at the Willis-Knighton Cancer Center in Shreveport, Louisiana, have achieved high levels of quality care, ease of use and speed of treatment in 11 months on IBA’s Proteus One compact proton therapy system.

After a record-setting 11 month installation with patient treatment beginning in September 2014, the Willis-Knighton team continues to set new records by employing a compact proton therapy system that treats clinically with pencil beam scanning (PBS). In addition to treating more common indications such as the brain and prostate, PBS has accelerated their ramp speed by enabling new applications such as breast, head and neck, esophageal lung, spine cancer, pediatric malignancies and various pelvis indications.

By working together with IBA, the Willis Knighton team is currently averaging 15 minutes per patient for most indications, even with multiple fields, resulting in a daily volume of 20 patients per eight-hour day. They expect that volume to increase based upon the even faster treatment times and expanded applications that Advanced Image Guidance with cone beam computed tomography (CBCT) will bring them. IBA’s Cone Beam CT is the only volumetric imaging solution to have obtained marketing authorization by the U.S. Food and Drug Administration (FDA) and is in clinical use daily.

Lane R. Rosen, M.D., director of radiation oncology at the Willis-Knighton Cancer Center, added: “The Proteus One has exceeded all of our expectations. We are very excited to have intensity modulated proton therapy and cone beam CT imaging available for our patients. Both Willis-Knighton and IBA teams have been partnering at each step to ensure a smooth transition from installation to first treatment and beyond during the ramp-up of operations. We have met or exceeded all of our expectations with this collaboration and are looking forward to even more treatment options for our patients in the future"

For more information: www.iba-worldwide.com

Related Content

The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. #ASTRO2018 #ASTRO #ASTRO18

The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. 

News | Computed Tomography (CT) | October 19, 2018
October 19, 2018 – At the 2018 American Society of...
IBA's Proteus system and proton therapy solutions will be discussed at ASTRO 2018. #ASTRO18 #ASTRO #ASTRO2018
News | Proton Therapy | October 19, 2018
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and t
IBA Dosimetry Enters Interoperability Agreement With Varian for Dolphin Monitoring
News | Radiation Therapy | October 17, 2018
IBA (Ion Beam Applications S.A.) announced it has entered into an agreement with Varian with the goal of validating the...
Boston Scientific Closes Acquisition of Augmenix Inc.
News | Prostate Cancer | October 17, 2018
Boston Scientific Corp. announced the close of its acquisition of Augmenix Inc., developer of the SpaceOAR Hydrogel...
Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition
News | Patient Engagement | October 15, 2018
Varian announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based,...
New Guideline for Prostate Cancer Supports Shortened Radiation Therapy
News | Prostate Cancer | October 12, 2018
Three prominent medical societies issued a new clinical guideline for physicians treating men with early-stage prostate...
Surgery, Radiation Therapy Equally Effective in Treating Oropharyngeal Cancer
News | Radiation Therapy | October 09, 2018
A new study by researchers at UT Southwestern Medical Center found no major long-term differences in the effectiveness...
Videos | Treatment Planning | October 08, 2018
Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, descri